Name of Drug:
Generic:                                 Trade Name:
Ondansetron                              Zofran
 Classification:
Pharmacologic                            Therapeutic:                               FDA category
Antiemetic                               Analgesic, antipyretic, anti-inflammatory, Pregnancy
                                         Nonopiod analgesic                         Category B
Mechanism of Action/Uses:
Used prior to surgery; Used for chemo pts
Blocks specific receptor sites (5-HT3), which are associated with nausea and vomiting in the
Chemoreceptor trigger zone, centrally, and at specific sites peripherally.
Correct Dosage Range and Route:
       Adult Dosage:
       PO, IV, IM 4-32 mg
Common Side Effects:
Dizziness, Constipation (sedating, but not as sedating as phenergan)
Contraindications:
Contains Aspartame—do not use in pts w/ phenylketonuria (rare condition in which a baby is born
without the ability to properly break down an amino acid called phenylalanine)
        Nursing Process:
             • More expensive than phenergan, but has less sedating effect
             • Often used for N/V in chemo pts
             • Crosses placenta, may enter breast milk
Pre-administration Assessment
Ask how much have they been vomiting?
Interventions/Patient Teaching
Be sure the timing of the drug corresponds with chemo/radiation tx
Evaluation
Monitor I&O, liver enzymes